DSI Announces Its Acquisition by ProductLife Group

DSI Introduces New, Hands-On Opportunity for Drug Sponsors to Learn from CMC and Regulatory Subject Matter Experts
July 31, 2020

DSI Announces Its Acquisition by ProductLife Group

(Harleysville, PA; April. 28, 2021) – We could not be more pleased to become part of a global leader in the life sciences regulatory and compliance industry. Joining PLG is exciting both for DSI as a business and for our clients, who will now have access to additional specialist expertise and international coverage spanning more than 100 countries.

READ PRESS RELEASE

About DSI

Design Space InPharmatics (DSI), is an Industry Leader in Regulatory Drug Development. ARE YOU DEVELOPING PRODUCTS WITH THE INTENTION OF MARKETING, LICENSING, OR DIVESTING?

DSI provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and cellular and gene therapy products.

Since 2007 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.

Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.

© 2021 Design Space InPharmatics, LLC. All rights reserved. Corresponding logos are registered trademarks of Design Space InPharmatics, LLC